Aminoglycoside levels in critically ill surgical patients: The implications of physiologic criteria of sepsis

Southern Medical Journal

Volumn 90, Issue 1, 1997, Pages 33-36

  Cornwell III, Edward E ^a,b   Belzberg, Howard ^a   Berne, Thomas V ^a   Kern, Jack W ^a   Henriques, Gavin ^a   Asensio, Juan A ^a   Demetriades, Demetrios ^a  

^a LAC+USC Medical Center ^*

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; TOBRAMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CRITICAL ILLNESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDICAL RECORD; RETROSPECTIVE STUDY; SEPSIS; SURGICAL PATIENT;

EID: 0031017559     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199701000-00007     Document Type: Article

References (23)

1. Chelluri L, Warren J, Jastremski MS: Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients. Chest 1987; 95:1295-1297
2. Whipple JK, Ausman RK, Franson T, et al: Effect of individualized pharmacokinetic dosing on patient outcome. Crit Care Med 1991; 19:1480-1485
3. Hollingsed TC, Harper DJ, Jennings JP, et al: Aminoglycoside dosing in burn patients using first-dose pharmacokinetics. J Trauma 1993; 35:394-398
4. Franson T, Quebbeman EJ, Whipple J, et al: Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods. Crit Care Med 1988; 16:840-843
5. Reed RL II, Wu AH, Miller-Crotchett P, et al: Pharmacokinetic monitoring of nephrotoxic antibiotics in surgical intensive care patients. J Trauma 1989; 29:1462-1468
6. Dasta J, Armstrong D: Variability in aminoglycoside pharmacokinetics in critically ill surgical patients. Crit Care Med 1988; 16:327-330
7. Oparaoji E, Cornwell E, Hekmak E, et al: Aminoglycoside volume of distribution in postoperative patients with septic shock. Clin Pharmacol 1993; 12:131-134
8. Chelluri L, Jastremski M: Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Crit Care Med 1987; 15:1143-1145
9. Watling SM, Dasta JF: Aminoglycoside dosing considerations in intensive care unit patients. Ann Pharmacother 1993; 27:351-357
10. Niemec P, Allo M, Miller CF: Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care. Arch Surg 1987; 122:207-212
11. Summer W, Michael J, Lipsky J: Initial aminoglycoside levels in the critically ill. Crit Care Med 1983; 11:948-950
12. Moore R, Smith C, Lietman PS: The association of aminoglycoside plasma levels with mortality in patients with gram negative bacteremia. J Infect Dis 1984; 149:443-148
13. Deziel-Evans LM, Murphy JE, Job ML: Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides. Clin Pharmacol 1986; 5:319-324
14. Moore RD, Lietman PS, Smith CR: Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987; 155:93-99
15. Noone P, Parsons TMC, Pattison JR, et al: Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. BMJ 1974; 1:477-481
16. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-827
17. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 1991; 324:429-436
18. Zaske DE, Cipolle RJ, Rotschafer JC: Gentamicin pharmacokinetics in 1640 patients: methods for control of serum concentrations. Antimicrob Agents Chemother 1982; 21:407
19. Townsend PL, Fink M, Stein K, et al: Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients. Crit Care Med 1989; 17:154-157
20. Mann HJ, Fuhs DW, Awang R, et al: Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharmacol 1987; 6:148-153
21. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:64-868
22. Bone RC, Fisher CJ Jr, Clemmer TP, et al: Sepsis syndrome: a valid clinical entity. Crit Care Med 1989; 17:389-393
23. Vallet B, Chopin C, Curtis SE, et al: Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study. Crit Care Med 1993; 21:1868-1874